评估最少的常见瘤数据元素在加强临床观察研究中的适用性
May Terry1, Janet L Espirito2, Lisa Deister2
1MITRE Corporation, Bedford, MA.
JCO clinical cancer informatics
|August 29, 2025
概括
最小的共同瘤数据元素 (mCODE) 标准部分支持现实世界的证据研究. 需要进行全面的癌症患者表征,治疗模式和结果分析.
科学领域:
- 癌症学
- 卫生信息学
- 现实世界证据研究
背景情况:
- 现实世界的证据对于了解癌症治疗至关重要.
- 需要标准化的数据元素来促进RWE研究.
- 最小的共同瘤数据元素 (mCODE) 标准旨在标准化瘤数据.
研究的目的:
- 评估mCODE标准适用于RWE研究.
- 评估mCODE在癌症患者和疾病特征,治疗模式和结果方面的能力.
- 确定mCODE的漏洞,以进行全面的观测研究.
主要方法:
- 在关键RWE类别中定义研究问题.
- 将问题分解为临床信息元素.
- 将元素映射到mCODE模型中,并确定漏洞.
- 将漏洞归类为模型缺陷或数据可用性问题.
主要成果:
- mCODE完全支持患者的表征.
- 在疾病特征,治疗模式和健康结果方面,mCODE存在重大差距.
- 在治疗方案和治疗结果中发现了特定的缺陷.
- 对于强大的观察研究,mCODE模型需要增强.
结论:
- mCODE部分适用于观察性RWE研究.
- 虽然对患者和疾病的表征有希望,但mCODE需要扩展.
- 需要额外的数据元素来充分支持治疗模式和结果的分析.
相关概念视频
Observational Studies
9.0K
Observational studies are a type of analytical study where researchers observe events without any interventions. In other words, the researcher does not influence the response variable or the experiment's outcome.
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
9.0K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Study Designs in Epidemiology
410
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
410
Clinical Trials
7.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.8K
Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448


